Biotech company StemoniX nets $14.4 mln Series B
Minnesota-based StemoniX Inc, a biotech company, has secured $14.4 million in Series B funding. Brightstone Venture Capital led the round with participation from other investors that included Crescent Ridge Partners, SEED San Diego, Alumni Ventures Group, Keshif Ventures and Mayo Clinic.
28 February 2019•1 min read
